Send Message
Contact Us

Contact Person : Jimmy Tian

Phone Number : 86-18602905046

WhatsApp : +8618602905046

Free call

Detail Information

Country Of Origin: India Form: Injection
Storage Conditions: Store At Room Temperature Warnings: Do Not Use In Pregnant Or Breastfeeding Women
Contraindications: Hypersensitivity To The Active Substance Or To Any Of The Excipients Shelf Life: 36 Months
Indication: Treatment Of Hormone Receptor-positive Metastatic Breast Cancer Adverse Reactions: Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia
High Light:

Hormone Receptor Positive Metastatic Breast Fulvestrant

,

Injection Fulvestrant Powder

,

500mg Fulvestrant Pharmaceutical Intermediates

Product Description

Product Description:

Fulvestrant, also known as Faslodex, is a type of hormone therapy developed by Pfizer, and manufactured in India. It is an injectable medication with a shelf life of 36 months. The active ingredient in Fulvestrant is a steroid hormone known as estradiol, which is used to treat certain types of breast cancer. It is typically used to treat postmenopausal women with hormone receptor-positive, metastatic breast cancer that has progressed despite treatment with other hormone therapies. It is not intended for use in pregnant or breastfeeding women, and should be used with caution in women with liver or kidney problems.

Faslodex is a fast-acting injection that works by blocking the action of estrogen, which can help slow or stop the growth of cancer cells. It is usually given as a single-dose injection every four weeks, and the cost of Faslodex can vary depending on the patient's insurance coverage. Common side effects of Faslodex include hot flashes, joint pain, fatigue, nausea, and headache. Patients should talk to their doctor if any of these side effects become severe or do not go away.

 

Features:

  • Product Name: Fulvestrant
  • Dosage: 250mg Intramuscularly Once Every 28 Days
  • Active Ingredient: Fulvestrant
  • Adverse Reactions: Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia
  • Pack Size: 1 Vial
  • Storage Conditions: Store At Room Temperature
 

Technical Parameters:

Attribute Value
Administration Intramuscular
Country of Origin India
Shelf Life 36 Months
Product Name Fulvestrant
Strength 500mg/5ml
Manufacturer Pfizer
Storage Conditions Store At Room Temperature
Pack Size 1 Vial
Active Ingredient Fulvestrant
Adverse Reactions Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia
 

Applications:

Fulvestrant, also known as Faslodex, is a fulvestrant injection manufactured by Pfizer. It is administered via intramuscular injection and has a shelf life of 36 months. The active ingredient, Fulvestrant, is indicated for the treatment of hormone receptor-positive metastatic breast cancer. It is an effective and reliable treatment option for individuals with this condition.

 

Support and Services:

Technical Support and Service for Fulvestrant

We offer a comprehensive range of technical support and services for Fulvestrant, including:

  • Troubleshooting and technical advice
  • Installation, maintenance and repair services
  • Training and education services
  • Product customization and optimization services
  • Software updates and upgrades
  • 24/7 online customer service

For more information on our technical support and services for Fulvestrant, please visit our website or contact us directly.

 

FAQ:

Q: What is Fulvestrant?
A: Fulvestrant is a hormonal therapy drug used to treat certain types of breast cancer in postmenopausal women.
Q: How does Fulvestrant work?
A: Fulvestrant works by blocking the effects of the hormone estrogen on tumor cells. This can help stop cancer cells from growing and spreading.
Q: What is the recommended dosage of Fulvestrant?
A: The recommended dosage of Fulvestrant is 500 mg given intramuscularly on Days 1, 15, and 29 and then monthly thereafter.
Q: What are the side effects of Fulvestrant?
A: Common side effects of Fulvestrant include nausea, hot flashes, headache, fatigue, and joint pain.
Q: Who should not take Fulvestrant?
A: Fulvestrant is not recommended for use in pregnant or breastfeeding women, as it may be harmful to an unborn or nursing baby.

You Might Be Into These
Get in touch with us

Enter Your Message

sales@libang.com.cn
+8618089290889